swine
influenza
viru
siv
major
caus
acut
respiratori
infect
pig
popul
worldwid
caus
agent
type
influenza
virus
mainli
subtyp
main
rout
transmiss
direct
contact
infect
uninfect
anim
close
contact
particularli
common
anim
transport
intens
farm
may
also
increas
risk
transmiss
pig
rais
product
unit
high
anim
densiti
siv
infect
result
fever
sneez
cough
difficulti
breath
decreas
appetit
result
weight
loss
poor
growth
siv
caus
signific
product
loss
especi
complic
secondari
infect
porcin
respiratori
tract
epitheli
cell
express
sialic
acid
receptor
util
avian
mammalian
influenza
virus
pig
therefor
consid
mix
vessel
new
humanavian
influenza
viru
reassort
potenti
caus
signific
respiratori
diseas
even
pandem
human
thu
control
siv
econom
import
also
paramount
public
health
sinc
current
licens
antivir
drug
avail
pig
steril
immun
achiev
current
vaccin
posit
effect
prevent
andor
cours
clinic
diseas
achiev
nutrit
supplement
would
highli
use
effect
zinc
zn
variou
probiot
bacteria
cours
bacteri
infect
pig
studi
intens
howev
publish
inform
effect
feed
supplement
respect
viru
infect
scarc
probiot
bacteria
part
gut
microbiom
report
promot
host
defens
modul
immun
function
evid
specif
probiot
alter
monocyt
natur
killer
cell
function
evid
also
accumul
probiot
boost
antibodi
respons
oral
system
administ
vaccin
e
faecium
ncimb
author
eu
probiot
feed
addit
pig
seem
suitabl
probiot
allow
us
studi
possibl
antivir
effect
demonstr
e
faecium
strain
modul
intestin
immun
system
sow
piglet
affect
shed
porcin
enter
virus
vitro
experi
also
show
direct
antivir
effect
e
faecium
enter
nonenter
virus
potenti
mechan
includ
pathogen
exclus
mean
competit
attach
well
induct
cytokin
signal
molecul
might
stimul
hostcel
immun
defens
zn
essenti
trace
element
cofactor
enzym
class
cover
pig
requir
ppm
provid
dietari
supplement
ad
diet
mostli
zn
oxid
zno
addit
also
shown
feed
high
zno
level
ppm
piglet
stimul
growth
prevent
postwean
diarrhea
howev
growerfinish
pig
high
level
zinc
typic
sustain
zinc
toxic
relat
dietari
level
durat
feed
publish
inform
antivir
zn
effect
viru
avail
cell
cultur
work
nutrit
studi
human
less
studi
involv
livestock
human
zn
util
frequent
attempt
treat
variou
viru
infect
aid
prophylaxi
result
suggest
zn
directli
interact
viral
structur
compon
influenc
viru
replic
also
wide
accept
zn
affect
immun
respons
cellular
level
well
level
recipi
organ
cell
cultur
studi
high
zn
concentr
addit
compound
stimul
cellular
import
zn
found
inhibit
replic
variou
rna
virus
includ
influenza
viru
sinc
data
efficaci
probiot
treatment
zn
supplement
viru
infect
vivo
limit
especi
respect
extraintestin
effect
feed
supplement
aim
studi
explor
system
effect
e
faecium
high
level
zn
oxid
feed
siv
vaccin
infect
report
clearli
demonstr
system
effect
treatment
especi
regard
clinic
paramet
humor
immun
respons
increas
follow
e
faecium
znhigh
supplement
influenza
viru
use
challeng
infect
viral
stock
produc
madindarbi
canin
kidney
mdck
cell
inactiv
trival
vaccin
idt
biologika
gmbh
dessaurosslau
germani
contain
three
main
swine
influenza
subtyp
use
studi
probiot
e
faecium
ncimb
appli
commerci
probiot
feed
addit
lbc
dsm
nutrit
product
ltd
kaiseraugst
switzerland
microencapsul
form
mix
diet
wean
piglet
concentr
coloni
form
unit
cfu
kg
feed
zno
either
ad
high
dose
znhigh
mgkg
diet
pharmacolog
level
age
day
switch
medium
dose
znmed
mgkg
diet
max
allow
eu
level
addit
zno
ad
znlow
mgkg
diet
znlow
diet
repres
regular
feed
anim
znlow
group
therefor
consid
control
throughout
paper
anim
experiment
approv
local
anim
welfar
author
landesamt
landwirtschaft
lebensmittelsicherheit
und
fischerei
rostock
mecklenburgvorpommern
germani
registr
number
piglet
n
rais
institut
freie
berlin
wean
age
day
age
pig
randomli
assign
three
differ
diet
znlow
znhigh
e
faecium
kept
group
pen
per
diet
high
zn
level
fed
age
day
order
avoid
toxic
effect
diet
reduc
medium
level
znmed
half
piglet
one
pen
per
treatment
vaccin
intramuscularli
vac
twice
day
commerci
siv
vaccin
total
treatment
group
contain
piglet
five
day
viru
infect
piglet
transport
facil
friedrichloefflerinstitut
insel
riem
hous
hepafilt
isol
unit
constant
pig
test
presenc
siv
antibodi
commerci
avail
elisa
target
viral
nucleoprotein
id
influenza
competit
idvet
grabel
franc
prior
infect
day
age
piglet
inocul
intranas
rout
ml
siv
titer
use
lma
intranas
mucos
atom
devic
teleflex
medic
gmbh
kernen
germani
half
piglet
group
kill
dpi
respect
iv
inject
mlkg
bodi
mass
intervet
deutschland
gmbh
germani
intramuscular
induct
anesthesia
mgkg
bodi
mass
ketamin
serumwerk
bernburg
ag
bernburg
germani
mgkg
bodi
mass
azaperon
janssencilag
gmbh
neuss
germani
experi
anim
clinic
monitor
daili
develop
clinic
sign
includ
fever
fatigu
anorexia
dyspnea
cough
bodi
weight
record
weekli
wean
infect
necropsi
dpi
exsanguin
blood
sampl
taken
daili
second
vaccin
serolog
analys
nasal
buccal
fecal
swab
collect
daili
analysi
viru
shed
day
necropsi
sampl
taken
nasal
turbin
lung
apic
middl
accessori
lobe
sampl
organ
prepar
histolog
analysi
necropsi
lung
immedi
examin
macroscop
photograph
taken
analysi
histopatholog
small
section
organ
fix
buffer
formalin
fix
tissu
dehydr
embed
paraffin
section
cut
histolog
examin
lung
section
portion
consist
affect
gross
lesion
welldemarc
purpl
dark
red
area
tissu
consolid
stain
use
hematoxylineosin
h
e
standard
stain
protocol
examin
microscop
examin
tissu
section
studi
conduct
blind
fashion
veterinari
pathologist
lesion
sever
score
distribut
lesion
within
section
examin
follow
visibl
chang
mild
chang
minim
differ
normal
moder
chang
sever
diffus
distribut
chang
develop
influenza
virusspecif
immun
respons
analyz
id
influenza
competit
elisa
optic
densiti
od
reaction
measur
nm
nm
micropl
reader
tecan
crailsheim
germani
result
report
ratio
nm
sampl
neg
control
nm
nm
n
includ
kit
posit
cutoff
sn
hemagglutin
inhibit
hi
assay
perform
use
solut
chicken
erythrocyt
nacl
hemagglutin
unit
sera
pretreat
receptor
destroy
enzym
cholera
filtrat
sigmaaldrich
st
loui
usa
remov
nonspecif
inhibitor
adsorb
onto
chicken
erythrocyt
remov
unspecif
agglutin
factor
test
perform
accord
standard
procedur
twofold
dilut
start
evalu
chang
cellular
composit
peripher
blood
siv
infect
whole
blood
analyz
use
autom
hematolog
analys
sysmex
corpor
hyogo
japan
number
neutrophil
lymphocyt
monocyt
determin
nasal
buccal
fecal
swab
taken
place
vial
contain
serumfre
cellcultur
medium
store
analysi
viral
rna
extract
nasal
buccal
swab
taken
dpi
fecal
swab
dpi
use
dna
mini
kit
qiagen
hilden
germani
kingfish
flex
magnet
particl
processor
thermo
fisher
scientif
waltham
usa
swab
elut
ml
serumfre
cellcultur
media
use
rna
extract
ave
buffer
realtim
revers
transcriptas
rtqpcr
quantif
siv
copi
number
perform
use
paninfluenza
assay
vitrotranscrib
rna
standard
peripher
blood
mononuclear
cell
pbmc
subject
multicolor
immunostain
porcin
cell
surfac
marker
flow
cytometri
analysi
use
bd
bd
bioscienc
heidelberg
germani
heparin
blood
sampl
stain
antibodi
mix
tabl
respect
isotyp
also
includ
assay
incub
min
dark
cell
wash
fluorescenceactiv
cell
sort
fac
buffer
bsa
sodium
bicarbon
sodium
azid
hbss
centrifug
min
antibodi
mix
mix
mix
ad
cell
wash
centrifug
last
wash
step
contamin
erythrocyt
lyse
osmosi
distil
water
sampl
analyz
lung
mononuclear
cell
isol
freshli
euthan
piglet
remov
lung
trachea
bronchu
left
lung
lavag
ml
pb
ph
use
flexibl
tube
collect
bronchoalveolar
lavag
bal
sampl
centrifug
min
pellet
resuspend
fac
buffer
stain
describ
result
flow
cytometri
analyz
use
softwar
treestar
ashland
usa
base
cell
receptor
gdtcr
stain
characterist
subpopul
group
follow
cell
thelper
th
cell
activ
helper
cell
cytotox
lymphocyt
ctl
thmemori
cell
natur
killer
nk
cell
antibodyform
andor
memori
b
cell
result
analyz
mix
model
fix
effect
time
diet
time
diet
elisa
hi
assay
data
diet
vaccin
diet
vaccin
lesion
score
data
time
diet
vaccin
time
diet
time
vaccin
diet
vaccin
time
diet
vaccin
qrtpcr
blood
count
flow
cytometri
data
one
random
effect
anim
posthoc
test
lsd
appli
case
signific
effect
calcul
perform
version
ibm
armonk
ny
usa
graphpad
prism
graphpad
softwar
inc
la
jolla
ca
usa
clinic
siv
infect
caus
mild
symptom
figur
fever
sporad
observ
averag
bodi
temperatur
lowest
e
faeciumvac
group
throughout
observ
period
siv
infect
mean
temperatur
spike
vaccin
znlow
group
dpi
figur
significantli
higher
weekli
weight
gain
record
infect
e
faecium
group
period
day
age
regardless
vaccin
figur
compar
bodi
weight
exsanguin
mean
bodi
weight
vaccin
nonvaccin
znhigh
e
faecium
fed
group
increas
siv
infect
dpi
dpi
weight
declin
znlow
group
time
point
figur
vaccin
result
reduc
frequenc
parenchym
consolid
lung
piglet
diet
group
figur
nonvaccin
anim
show
macroscop
figur
microscop
lesion
dpi
figur
right
middl
lung
lobe
exhibit
highest
frequenc
extent
lesion
macroscop
therefor
section
lobe
analyz
score
histopatholog
examin
affect
pig
present
mild
score
sever
score
interstiti
bronchopneumonia
domin
lymphocyt
infiltr
figur
sporad
bronchiol
alveoli
contain
cellular
debri
lymphocyt
fewer
histiocyt
scatter
neutrophil
accompani
bronchiolar
epitheli
degener
necrosi
vaccin
group
reduc
frequenc
moder
score
peribronchi
lesion
prevent
sever
score
interstiti
lung
lesion
observ
although
signific
differ
differ
diet
appar
vaccin
nonvaccin
anim
vaccin
anim
receiv
e
faecium
diet
show
lowest
lesion
score
figur
viru
shed
analyz
qrtpcr
nasal
buccal
swab
infect
dpi
figur
fecal
swab
dpi
viru
genom
detect
sampl
infect
fecal
swab
data
shown
vaccin
anim
approxim
reduc
viral
load
compar
nonvaccin
anim
nasal
buccal
swab
figur
signific
differ
howev
dietari
treatment
group
although
tendenc
toward
lower
viru
shed
nose
observ
e
faeciumtr
anim
vaccin
piglet
develop
antibodi
detect
np
protein
elisa
day
infect
day
second
vaccin
figur
significantli
higher
antibodi
could
detect
e
faeciumvac
group
compar
znlowvac
group
day
p
day
challeng
infect
p
well
p
dpi
p
elisa
result
confirm
hi
assay
figur
found
gener
effect
feed
e
faecium
znhigh
diet
vaccin
anim
significantli
higher
antibodi
titer
detect
e
faeciumvac
group
day
siv
infect
dpi
p
dpi
p
dpi
p
significantli
higher
antibodi
also
detect
znhighvac
group
day
siv
infect
p
dpi
p
dpi
p
nonvaccin
piglet
antibodi
could
bare
detect
dpi
either
method
hematolog
paramet
peripher
blood
examin
siv
infect
use
autom
analyz
shown
tabl
number
monocyt
lymphocyt
show
differ
group
wherea
reduc
number
neutrophil
observ
znhigh
group
flow
cytometri
immun
cell
phenotyp
pbmc
subpopul
perform
dpi
dpi
viru
infect
led
slight
decreas
frequenc
th
cell
dpi
contrast
increas
percentag
ctl
thmemori
cell
antibodyform
andor
memori
b
cell
nk
cell
observ
dpi
vaccin
nonvaccin
anim
regard
dietari
effect
signific
differ
treatment
group
observ
subpopul
infect
figur
dpi
challeng
infect
signific
differ
found
singl
time
point
higher
ctl
percentag
p
found
znhighvac
group
compar
control
znlowvac
group
dpi
nonvaccin
group
higher
cell
percentag
p
found
e
faecium
group
compar
znlow
group
dpi
final
significantli
lower
antibodyproduc
andor
memori
b
cell
number
observ
e
faecium
group
compar
znlow
group
p
dpi
nonvaccin
pig
immun
cell
phenotyp
bal
cell
examin
necropsi
dpi
dpi
observ
increas
percentag
gamma
delta
tcell
activ
bcell
activ
tcell
dpi
infect
compar
dpi
influenc
vaccin
dietari
treatment
figur
studi
investig
effect
feed
supplement
e
faecium
higher
dietari
zno
level
vaccin
challeng
swine
influenza
viru
clinic
followup
virolog
outcom
well
humor
immun
cellular
immun
respons
record
analyz
knowledg
inform
first
collect
describ
pig
livestock
therefor
provid
import
contribut
respect
assess
use
lack
thereof
feed
supplement
import
viral
diseas
challeng
infect
siv
caus
mild
symptom
line
observ
studi
confirm
import
good
sanitari
statu
provid
experiment
prevent
secondari
infect
observ
significantli
higher
bodi
weight
gain
e
faecium
treatment
group
wean
infect
also
made
studi
wherea
growthpromot
effect
znhigh
diet
observ
other
could
confirm
compar
bodi
weight
challeng
infect
appear
mean
bodi
weight
piglet
znhigh
e
faecium
increas
dpi
dpi
decreas
znlow
group
figur
result
might
indic
better
faster
recoveri
infect
anorexia
reduc
durat
probiot
znhigh
group
promin
find
obtain
studi
develop
higher
sivspecif
elisa
hi
antibodi
level
znhigh
particularli
e
faecium
treat
vaccin
group
two
day
well
day
viru
infect
figur
increas
antibodi
respons
vaccin
group
receiv
higher
zn
level
diet
compar
znlow
diet
group
might
indic
suboptim
zn
suppli
znlow
group
restor
sinc
shown
zn
defici
impair
bcell
function
also
possibl
normal
antibodi
respons
znlow
group
improv
addit
zn
suppli
although
shown
elsewher
yet
data
also
demonstr
dietari
supplement
e
faecium
abl
boost
antibodi
level
similar
observ
also
made
previou
studi
use
anoth
probiot
strain
howev
other
specul
possibl
mechan
antibodi
titer
vaccin
appli
parenter
might
enhanc
oral
probiot
appli
influenza
vaccin
intramuscularli
assum
immun
respons
mainli
gener
tributari
axillari
lymph
node
commun
must
therefor
exist
probiot
bacteria
gut
cell
initi
immun
respons
distant
site
explain
observ
effect
previous
argu
subcellular
fragment
probiot
may
enter
bloodstream
direct
albeit
weak
adjuv
effect
distant
lymph
node
anoth
possibl
explan
could
feed
intak
probiot
fragment
might
inhal
andor
directli
get
contact
epitheli
cell
nasopharynx
induc
cytokin
signal
molecul
adjuv
effect
interestingli
e
faecium
group
diet
base
znlow
diet
thu
could
possibl
lack
zn
compens
probiot
supplement
also
could
possibl
synergist
effect
e
faecium
optim
elev
zn
induct
even
higher
antibodi
level
lung
nonvaccin
anim
show
extens
macroscop
lesion
figur
nonvaccin
anim
microscop
evalu
reveal
vaccin
reduc
sever
microscop
lesion
figur
howev
dietari
influenc
observ
appar
data
also
show
vaccin
result
steril
immun
reduc
number
anim
shed
viru
well
amount
viru
shed
nose
buccal
site
figur
fecal
shed
also
test
agreement
literatur
viru
could
detect
despit
higher
antibodi
level
stronger
reduct
viru
shed
achiev
e
faecium
znhigh
supplement
vaccin
anim
report
other
increas
antibodi
level
necessarili
mean
antibodi
exhibit
high
specif
affin
especi
true
antibodi
induc
inactiv
vaccin
unlik
follow
live
vaccin
administr
natur
infect
viru
deliv
secondari
lymphat
organ
present
dendrit
cell
elicit
optim
virusneutr
antibodi
respons
hematolog
reveal
transient
reduc
neutrophil
number
vaccin
nonvaccin
anim
receiv
znhigh
diet
zninduc
neutropenia
describ
man
obvious
studi
neutrophil
number
still
suffici
avoid
neg
effect
cours
siv
infect
need
emphas
znhigh
diet
reduc
znmed
diet
ppm
infect
reduc
possibl
toxic
effect
therefor
rule
continu
high
zn
dose
might
neg
effect
health
individu
accord
literatur
cellular
immun
respons
cell
well
antibodyproduc
b
cell
make
import
contribut
control
influenza
viru
replic
viru
clearanc
infect
th
cell
primarili
stimul
antibodi
cytokin
product
prolifer
ctl
ctl
respons
mainli
direct
conserv
influenza
viru
protein
np
consequ
robust
ctl
respons
also
confer
protect
heterolog
influenza
viru
challeng
inactiv
vaccin
poor
induc
cellular
immun
respons
accordingli
observ
effect
vaccin
cellular
immun
respons
found
slight
decreas
th
cell
concomit
equal
slight
increas
ctl
antibodyproduc
b
cell
percentag
dpi
pbmc
regard
dietari
effect
found
signific
differ
e
faecium
znhigh
group
control
znlow
group
singl
time
point
prolong
effect
also
compar
percentag
immun
cell
phenotyp
cell
bal
fluid
necropsi
sinc
prolifer
respons
peripher
blood
fulli
reflect
site
infect
found
increas
percentag
gamma
delta
tcell
activ
bcell
activ
tcell
dpi
compar
dpi
vaccin
nonvaccin
anim
influenc
dietari
treatment
thu
seem
e
faecium
zn
supplement
neither
system
local
chang
cellular
immun
respons
siv
infect
substanti
summari
result
present
suggest
high
dose
zno
particularli
e
faecium
increas
humor
immun
respons
follow
siv
vaccin
support
recoveri
clinic
ill
howev
increas
respons
significantli
affect
viru
shed
develop
lung
lesion
challeng
infect
howev
use
combin
appropri
vaccin
feed
supplement
zno
andor
e
faecium
might
suitabl
improv
antibodi
respons
help
reduc
viru
shed
